I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strong..:
Helland, Thomas
;
Gjerde, Jennifer
;
Dankel, Simon N
...
Tamoxifen in the treatment of luminal breast cancer. Implications of active metabolites on gene expression, side effects and clinical outcome. , 2015
Link:
https://hdl.handle.net/1956/20462
RT Journal T1 <Title>The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strongly Down-Regulates Cytokeratin 6 (CK6) in MCF-7 Breast Cancer Cells</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftunivbergen:oai:bora.uib.no:1956_20462&Exemplar=1&LAN=DE A1 Helland, Thomas A1 Gjerde, Jennifer A1 Dankel, Simon N A1 Fenne, Ingvild Sveinsgjerd A1 Skartveit, Linn A1 Drangevåg, Andreas A1 Bozickovic, Olivera A1 Flågeng, Marianne Hauglid A1 Søiland, Håvard A1 Mellgren, Gunnar A1 Lien, Ernst Asbjørn PB Public Library of Science YR 2015 JF Tamoxifen in the treatment of luminal breast cancer. Implications of active metabolites on gene expression, side effects and clinical outcome LK http://dx.doi.org/https://hdl.handle.net/1956/20462 DO https://hdl.handle.net/1956/20462 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
